Clover Health Investments Corp (CLOV) Stock Forecast & Price Target
Clover Health Investments Corp · NASDAQ
$4.28-0.04 (-0.93%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Clover Health Investments Corp, 1 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets range widely, $2.50 to $5.50 (about 2.2x), a sign of real disagreement on valuation. The average target of $4.25 sits 1% below the current $4.28. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $0.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Clover Health Investments Corp.
As of Jul, 1 of 3 firms rate CLOV a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CLOV EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 1 analysts · -100% YoY
Next period, 1 analysts expect Clover Health Investments Corp to earn $0.00 a share (range $0.00 – $0.00), versus $0.00 a year earlier. Full-year consensus is $0.09, growing to $0.10 the year after.
REVENUE · NEXT QUARTER
$722.9M
Range $720.7M – $726.1M · 1 analysts · +46% YoY
Revenue is expected to reach $722.9M (range $720.7M – $726.1M), +45.6% year-over-year. Full-year consensus is $2.9B, rising to $3.4B next year.
Top analysts covering Clover Health Investments Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLOV.
#1
Richard Close
Canaccord Genuity
Buy
$4.20-1.9% to target
Coverage
—
+ Follow
#2
JY
Jonathan Yong
UBS
Hold
$4.75+11.0% to target
Coverage
—
+ Follow
#3
Whit Mayo
Leerink Partners
Hold
$2.50-41.6% to target
Coverage
—
+ Follow
#4
MH
Matt Hewitt
Craig-Hallum
Buy
No targeton CLOV
Coverage
—
+ Follow
CLOV stock forecast FAQ
What is CLOV's average 12-month price target?+
The 3 analysts with a live target average $4.25 for Clover Health Investments Corp over the next 12 months, ranging from a $5.50 high to a $2.50 low.
Is CLOV stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CLOV?+
The Street-high target is $5.50 (Canaccord Genuity), and the Street-low is $2.50 (Leerink Partners). The average of all 3 active targets is $4.25.
How many Wall Street analysts cover CLOV?+
3 analysts have an active rating on Clover Health Investments Corp, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering CLOV?+
Among analysts who currently cover CLOV, Richard Close of Canaccord Genuity has the strongest overall Quantellect track record. Their current call is Buy with a $4.20 target.
What is Clover Health Investments Corp's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 1 analysts. Full-year EPS is projected at $0.09, rising to $0.10 the following year.
How much revenue is Clover Health Investments Corp expected to report next quarter?+
Consensus revenue is $722.9M (range $720.7M – $726.1M). Full-year revenue is projected at $2.9B, growing to $3.4B next year.
Have analysts been upgrading or downgrading CLOV lately?+
As of Jul, 1 of 3 firms rate CLOV a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLOV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
